Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis.

Guiyoule A, Gerbaud G, Buchrieser C, Galimand M, Rahalison L, Chanteau S, Courvalin P, Carniel E.

Emerg Infect Dis. 2001 Jan-Feb;7(1):43-8.

2.

Vibrio cholerae O139 multiple-drug resistance mediated by Yersinia pestis pIP1202-like conjugative plasmids.

Pan JC, Ye R, Wang HQ, Xiang HQ, Zhang W, Yu XF, Meng DM, He ZS.

Antimicrob Agents Chemother. 2008 Nov;52(11):3829-36. doi: 10.1128/AAC.00375-08. Epub 2008 Aug 18.

3.

High-frequency conjugative transfer of antibiotic resistance genes to Yersinia pestis in the flea midgut.

Hinnebusch BJ, Rosso ML, Schwan TG, Carniel E.

Mol Microbiol. 2002 Oct;46(2):349-54.

4.

Novel plasmids and resistance phenotypes in Yersinia pestis: unique plasmid inventory of strain Java 9 mediates high levels of arsenic resistance.

Eppinger M, Radnedge L, Andersen G, Vietri N, Severson G, Mou S, Ravel J, Worsham PL.

PLoS One. 2012;7(3):e32911. doi: 10.1371/journal.pone.0032911. Epub 2012 Mar 30.

5.

Recent emergence of new variants of Yersinia pestis in Madagascar.

Guiyoule A, Rasoamanana B, Buchrieser C, Michel P, Chanteau S, Carniel E.

J Clin Microbiol. 1997 Nov;35(11):2826-33.

6.

Plasmid-mediated doxycycline resistance in a Yersinia pestis strain isolated from a rat.

Cabanel N, Bouchier C, Rajerison M, Carniel E.

Int J Antimicrob Agents. 2017 Oct 10. pii: S0924-8579(17)30363-1. doi: 10.1016/j.ijantimicag.2017.09.015. [Epub ahead of print]

PMID:
29030266
7.

Comparative efficacies of candidate antibiotics against Yersinia pestis in an in vitro pharmacodynamic model.

Louie A, Vanscoy B, Liu W, Kulawy R, Brown D, Heine HS, Drusano GL.

Antimicrob Agents Chemother. 2011 Jun;55(6):2623-8. doi: 10.1128/AAC.01374-10. Epub 2011 Apr 12.

8.

Multidrug resistance in Yersinia pestis mediated by a transferable plasmid.

Galimand M, Guiyoule A, Gerbaud G, Rasoamanana B, Chanteau S, Carniel E, Courvalin P.

N Engl J Med. 1997 Sep 4;337(10):677-80. No abstract available.

9.

Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.

Louie A, Heine HS, VanScoy B, Eichas A, Files K, Fikes S, Brown DL, Liu W, Kinzig-Schippers M, Sörgel F, Drusano GL.

Antimicrob Agents Chemother. 2011 Feb;55(2):822-30. doi: 10.1128/AAC.00818-10. Epub 2010 Nov 29.

10.

[Mobilization of plasmid determinants of Yersinia pestis using the plasmid pKA7].

Zarenkov MI, Lebedeva SA.

Mol Gen Mikrobiol Virusol. 1986 May;(5):16-20. Russian.

PMID:
3796653
11.

Multiple antimicrobial resistance in plague: an emerging public health risk.

Welch TJ, Fricke WF, McDermott PF, White DG, Rosso ML, Rasko DA, Mammel MK, Eppinger M, Rosovitz MJ, Wagner D, Rahalison L, Leclerc JE, Hinshaw JM, Lindler LE, Cebula TA, Carniel E, Ravel J.

PLoS One. 2007 Mar 21;2(3):e309.

12.

Global gene expression profile of Yersinia pestis induced by streptomycin.

Qiu J, Zhou D, Han Y, Zhang L, Tong Z, Song Y, Dai E, Li B, Wang J, Guo Z, Zhai J, Du Z, Wang X, Yang R.

FEMS Microbiol Lett. 2005 Feb 15;243(2):489-96.

13.

In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.

Wendte JM, Ponnusamy D, Reiber D, Blair JL, Clinkenbeard KD.

Antimicrob Agents Chemother. 2011 Aug;55(8):3752-7. doi: 10.1128/AAC.01481-10. Epub 2011 May 31.

14.

Lack of antimicrobial resistance in Yersinia pestis isolates from 17 countries in the Americas, Africa, and Asia.

Urich SK, Chalcraft L, Schriefer ME, Yockey BM, Petersen JM.

Antimicrob Agents Chemother. 2012 Jan;56(1):555-8. doi: 10.1128/AAC.05043-11. Epub 2011 Oct 24.

15.

A multicopy suppressor screening approach as a means to identify antibiotic resistance determinant candidates in Yersinia pestis.

Stirrett KL, Ferreras JA, Rossi SM, Moy RL, Fonseca FV, Quadri LE.

BMC Microbiol. 2008 Jul 21;8:122. doi: 10.1186/1471-2180-8-122.

16.

Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy.

Louie A, Deziel MR, Liu W, Drusano GL.

Antimicrob Agents Chemother. 2007 Aug;51(8):2661-7. Epub 2007 May 21.

17.

In silico comparison of Yersinia pestis and Yersinia pseudotuberculosis transcriptomes reveals a higher expression level of crucial virulence determinants in the plague bacillus.

Chauvaux S, Dillies MA, Marceau M, Rosso ML, Rousseau S, Moszer I, Simonet M, Carniel E.

Int J Med Microbiol. 2011 Feb;301(2):105-16. doi: 10.1016/j.ijmm.2010.08.013. Epub 2010 Oct 15.

PMID:
20951640
18.

Modulation of the low-calcium response in Yersinia pestis via plasmid-plasmid interaction.

Sample AK, Fowler JM, Brubaker RR.

Microb Pathog. 1987 Jun;2(6):443-53.

PMID:
3507558
19.
20.

Curing of four different plasmids in Yersinia pestis using plasmid incompatibility.

Ni B, Du Z, Guo Z, Zhang Y, Yang R.

Lett Appl Microbiol. 2008 Oct;47(4):235-40.

PMID:
19241516

Supplemental Content

Support Center